tiprankstipranks
Kyverna Therapeutics, Inc. (KYTX)
NASDAQ:KYTX
US Market

Kyverna Therapeutics, Inc. (KYTX) Income Statement

Compare
646 Followers

Kyverna Therapeutics, Inc. Income Statement

Last quarter (Q3 2024), Kyverna Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Kyverna Therapeutics, Inc.'s net income was $-34.49M. See Kyverna Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 7.03M$ 5.66M
Gross Profit
$ -1.71M$ 5.97M$ 5.07M
Operating Expenses
$ 62.41M$ 36.41M$ 32.00M
Depreciation and Amortization
$ 1.71M$ 1.05M$ 586.00K
EBITDA
$ -58.47M$ -27.78M$ -25.76M
Operating Income
$ -62.41M$ -29.38M$ -26.35M
Other Income/Expenses
$ 2.04M$ 491.00K$ -4.00K
Pretax Income
$ -60.37M$ -28.89M$ -26.35M
Net Income
$ -60.37M$ -28.89M$ -26.35M
Per Share Metrics
$ ―$ ―$ ―
Basic EPS
$ 0.00$ -1.12$ -1.02
Diluted EPS
$ 0.00$ -1.12$ -1.02
Weighted Average Shares Outstanding
673.62M 25.80M 25.80M
Weighted Average Shares Outstanding (Diluted)
673.62M 25.80M 25.80M
Currency in USD

Kyverna Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis